Enorama Pharma AB Total Liabilities
Enorama Pharma AB total liabilities. Based on the latest financial reports, Enorama Pharma AB (ERMA) has total liabilities worth Skr57.39 Million SEK (≈ $6.18 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Enorama Pharma AB defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Enorama Pharma AB (2014–2025)
Total liabilities of Enorama Pharma AB from 2014 to 2025. This chart illustrates how Enorama Pharma AB's total liabilities have evolved over time, based on quarterly financial data.
Enorama Pharma AB Competitors by Total Liabilities
The table below lists competitors of Enorama Pharma AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ODIGMA CONSULTANCY SOLUTIONS LTD
NSE:ODIGMA
|
India | Rs92.55 Million |
|
Mexican Gold Corp
V:MEX
|
Canada | CA$134.27K |
|
Sharc International Systems
F:IWIA
|
Germany | €4.86 Million |
|
WISDOM ED.INTL.HLD.HD-01
F:5Q4
|
Germany | €547.57 Million |
|
Slam Exploration Ltd.
V:SXL
|
Canada | CA$391.43K |
|
IL&FS Transportation Networks Limited
NSE:IL&FSTRANS
|
India | Rs520.81 Million |
|
Puri Global Sukses Tbk Pt
JK:PURI
|
Indonesia | Rp428.63 Billion |
|
FG Financial Group
NASDAQ:FGF
|
USA | $23.52 Million |
Liability Composition Analysis (2014–2025)
This chart breaks down Enorama Pharma AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Enorama Pharma AB.
Liquidity & Leverage Metrics
Enorama Pharma AB Total Liabilities Ratios Explained
Enorama Pharma AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 8.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Enorama Pharma AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Enorama Pharma AB (2014–2025)
The table below shows the annual total liabilities of Enorama Pharma AB from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr31.71 Million ≈ $3.41 Million |
+291.95% |
| 2024-12-31 | Skr8.09 Million ≈ $870.72K |
-45.50% |
| 2023-12-31 | Skr14.85 Million ≈ $1.60 Million |
-13.67% |
| 2022-12-31 | Skr17.20 Million ≈ $1.85 Million |
-41.86% |
| 2021-12-31 | Skr29.58 Million ≈ $3.18 Million |
-24.40% |
| 2020-12-31 | Skr39.13 Million ≈ $4.21 Million |
+10.52% |
| 2019-12-31 | Skr35.40 Million ≈ $3.81 Million |
+62.33% |
| 2018-12-31 | Skr21.81 Million ≈ $2.35 Million |
+168.41% |
| 2017-12-31 | Skr8.13 Million ≈ $874.50K |
+78.73% |
| 2016-12-31 | Skr4.55 Million ≈ $489.27K |
+71.95% |
| 2015-12-31 | Skr2.64 Million ≈ $284.54K |
+155.71% |
| 2014-12-31 | Skr1.03 Million ≈ $111.27K |
-- |
About Enorama Pharma AB
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells tobacco-free white snus in Sweden. It offers its products under the NIC-S brand name. The company was incorporated in 2006 and is based in Stockholm, Sweden.